Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 28, 2022

View Archived Issues

Structure-based psychedelic analogue discovery reported

Low penetrance of deleterious genetic variants observed in large cohorts

Loperamide shows antitumoral activity in TET2-mutated AML

Sophoridine derivatives show improved potency against triple-negative breast cancer

Novel nonviral engineered BAFF-CAR T cells show efficacy in multiple B-cell cancer models

Beta-elemene NO derivatives demonstrate potent antiglioma activity in vivo

Pfizer patents new JAK inhibitors

BridGene Biosciences divulges YAP1/TEAD interaction inhibitors

Gilgamesh Pharmaceuticals identifies new 5-HT2A receptor agonists

Bacainn Therapeutics synthesizes new NLRP inflammasome inhibitors

Chinese researchers discover new SST2 receptor ligands

Cereno advances CS-014 for cardiovascular diseases

PDS-0202 universal flu vaccine neutralizes multiple strains of influenza in preclinical studies

NBTXR3 improves survival in preclinical model of anti-PD-1-resistant lung cancer

Cocrystal selects oral antiviral candidates for SARS-CoV-2

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 4, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 4, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...